A phase II study of radiosurgery and temozolomide for patients with one to four brain metastases

被引：0
|
作者：
Fiveash, J. B.
Sawrie, S. M.
Guthrie, B. L.
Spencer, S. A.
Meredith, R. F.
Markert, J. M.
Nordal, R. A.
Conry, R. M.
Nabors, L. B.
机构：
[1] UAB, Wallace Tumor Inst, Birmingham, AL USA
[2] UAB, Birmingham, AL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2048
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases
    Christodoulou, C
    Bafaloukos, D
    Kosmidis, P
    Samantas, E
    Bamias, A
    Papakostas, P
    Karabelis, A
    Bacoyiannis, C
    Skarlos, DV
    ANNALS OF ONCOLOGY, 2001, 12 (02) : 249 - 254
  • [2] Temozolomide plus thalidomide in patients with brain metastases from melanoma - A phase II study
    Hwu, WJ
    Lis, E
    Menell, JH
    Panageas, KS
    Lamb, LA
    Merrell, J
    Williams, LJ
    Krown, SE
    Chapman, PB
    Livingston, PO
    Wolchok, JD
    Houghton, AN
    CANCER, 2005, 103 (12) : 2590 - 2597
  • [3] Temozolomide in combination with stereotactic radiosurgery for recurrent brain metastases: A phase I study.
    Roberge, D.
    Pouliot, J.
    Souhami, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] A phase II trial of temozolomide and vinorelbine for patients with recurrent brain metastases
    Iwamoto, F. M.
    Omuro, A. M.
    Raizer, J. J.
    Nolan, C. P.
    Hormigo, A.
    Lassman, A. B.
    Gavrilovic, I. T.
    Abrey, L. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] A phase II trial of temozolomide for patients with recurrent or progressive brain metastases
    Abrey, LE
    Olson, JD
    Raizer, JJ
    Mack, M
    Rodavitch, A
    Boutros, DY
    Malkin, MG
    JOURNAL OF NEURO-ONCOLOGY, 2001, 53 (03) : 259 - 265
  • [6] A phase II trial of temozolomide and vinorelbine for patients with recurrent brain metastases
    Iwamoto, Fabio
    Omuro, Antonio
    Raizer, Jeffrey
    Nolan, Craig
    Hormigo, Adilia
    Gavrilovic, Igor
    Abrey, Lauren
    NEURO-ONCOLOGY, 2007, 9 (04) : 524 - 525
  • [7] A Phase II Trial of Temozolomide for Patients with Recurrent or Progressive Brain Metastases
    Lauren E. Abrey
    Jon D. Olson
    Jeffrey J. Raizer
    Michelle Mack
    Ann Rodavitch
    Dina Y. Boutros
    Mark G. Malkin
    Journal of Neuro-Oncology, 2001, 53 : 259 - 265
  • [8] Phase II study of gamma knife radiosurgery and temozolomide (Temodar) for newly diagnosed brain metastases. Preliminary toxicity analysis
    Fiveash, JB
    Guthrie, B
    Markert, JM
    Spencer, SA
    Rosenfeld, SR
    Russo, SM
    Nabors, LB
    NEURO-ONCOLOGY, 2004, 6 (04) : 374 - 374
  • [9] Phase II Randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases
    Antonadou, D
    Paraskevaidis, M
    Sarris, G
    Coliarakis, N
    Economou, I
    Karageorgis, P
    Throuvalas, N
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) : 3644 - 3650
  • [10] Temozolomide for the treatment of brain metastases associated with metastatic melanoma: A phase II study
    Agarwala, SS
    Kirkwood, JM
    Gore, M
    Dreno, B
    Thatcher, N
    Czarnetski, B
    Atkins, M
    Buzaid, A
    Skarlos, D
    Rankin, EM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2101 - 2107
12345